rhodioloside has been researched along with Retinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, M; Zhang, Y | 1 |
| Dong, N; Li, S; Qiu, Q; Shi, X; Zhang, J | 1 |
2 other study(ies) available for rhodioloside and Retinal Diseases
| Article | Year |
|---|---|
[Salidroside alleviates retinopathy in diabetes rats by inhibiting oxidative stress and immune inflammation through activating PI3K/AKT pathway].
Topics: Animals; Blood Glucose; Diabetes Mellitus; Inflammation; Intercellular Adhesion Molecule-1; Male; NF-kappa B; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Retinal Diseases; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2023 |
Salidroside Prevents Hypoxia-Induced Human Retinal Microvascular Endothelial Cell Damage Via miR-138/ROBO4 Axis.
Topics: Blotting, Western; Endothelium, Vascular; Flow Cytometry; Gene Expression Regulation; Glucosides; Humans; Hypoxia; Male; MicroRNAs; Phenols; Retinal Diseases; Retinal Vessels | 2021 |